These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21428013)

  • 1. [If the brain is "divided"].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2011 Feb; 34(2):39. PubMed ID: 21428013
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
    Lashuel HA; Lansbury PT
    Q Rev Biophys; 2006 May; 39(2):167-201. PubMed ID: 16978447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration in normal brain aging and disease.
    Thal DR; Del Tredici K; Braak H
    Sci Aging Knowledge Environ; 2004 Jun; 2004(23):pe26. PubMed ID: 15190177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biomarkers in Alzheimer's disease].
    Borchard-Tuch C
    Med Monatsschr Pharm; 2011 Feb; 34(2):61-2. PubMed ID: 21428017
    [No Abstract]   [Full Text] [Related]  

  • 6. Maillard reaction versus other nonenzymatic modifications in neurodegenerative processes.
    Pamplona R; Ilieva E; Ayala V; Bellmunt MJ; Cacabelos D; Dalfo E; Ferrer I; Portero-Otin M
    Ann N Y Acad Sci; 2008 Apr; 1126():315-9. PubMed ID: 18079479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease.
    Ballmaier M; Memo M
    Funct Neurol; 2005; 20(2):69. PubMed ID: 15966269
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegenerative disorders with diffuse cortical Lewy bodies.
    Fleisher AS; Olichney JM
    Adv Neurol; 2005; 96():148-65. PubMed ID: 16383218
    [No Abstract]   [Full Text] [Related]  

  • 10. Capgras syndrome and its relationship to neurodegenerative disease.
    Josephs KA
    Arch Neurol; 2007 Dec; 64(12):1762-6. PubMed ID: 18071040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The complexes of degenerative dementias: an evolution from disease to spectrum].
    Robles A
    Neurologia; 2009; 24(6):399-418. PubMed ID: 19798607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology of mild cognitive impairment.
    Saito Y; Murayama S
    Neuropathology; 2007 Dec; 27(6):578-84. PubMed ID: 18021380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain imaging and neuropathologic mechanisms in Alzheimer's disease: vascular versus neurodegenerative and amyloid-beta versus tau.
    Menon PM; Vonsattel JP; Jolles PR
    J Alzheimers Dis; 2009; 18(2):419-27. PubMed ID: 19625742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution.
    Weisman D; Cho M; Taylor C; Adame A; Thal LJ; Hansen LA
    Neurology; 2007 Jul; 69(4):356-9. PubMed ID: 17646627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Jellinger KA
    Acta Neuropathol; 2009 Feb; 117(2):215-6; author reply 217-8. PubMed ID: 18985364
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's disease and dementia with Lewy bodies.
    Scott L
    Elder Care; 1999 Jun; 11(4):37-9. PubMed ID: 10614276
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of amyloid peptides to domain-swapped dimers of other amyloid-forming proteins may prevent their neurotoxicity.
    Taler-Verčič A; Zerovnik E
    Bioessays; 2010 Dec; 32(12):1020-4. PubMed ID: 21086533
    [No Abstract]   [Full Text] [Related]  

  • 19. A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease.
    Ishikawa A; Piao YS; Miyashita A; Kuwano R; Onodera O; Ohtake H; Suzuki M; Nishizawa M; Takahashi H
    Ann Neurol; 2005 Mar; 57(3):429-34. PubMed ID: 15732120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.